Will the FDA refuse approval in the face of the favourable ODAC 9 versus 1 vote?, page-54

I trade MSB and I got out at 5,2$. My thesis is that with 9 vs 1 recommendation the FDA approval is pretty much baked into the price at current levels. So the risk of the downside is much greater than the upside opportunity however I reckoning this a short term view other news like the covid application can move the SP materially higher. I am also starting to make a view that the FDA approval will create some buy back opportunity at lower SP as there could be many flocks of holders trying to sell as the rocket ship will struggle to take off and emotion selling will prevail. Just my opinion